3-175233990-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_207015.3(NAALADL2):c.605C>T(p.Thr202Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000609 in 1,608,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207015.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAALADL2 | NM_207015.3 | c.605C>T | p.Thr202Ile | missense_variant | 3/14 | ENST00000454872.6 | NP_996898.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAALADL2 | ENST00000454872.6 | c.605C>T | p.Thr202Ile | missense_variant | 3/14 | 1 | NM_207015.3 | ENSP00000404705 | P1 | |
NAALADL2 | ENST00000485853.5 | n.691C>T | non_coding_transcript_exon_variant | 3/4 | 1 | |||||
NAALADL2 | ENST00000473253.5 | n.837C>T | non_coding_transcript_exon_variant | 3/11 | 2 | |||||
NAALADL2 | ENST00000489299.5 | n.344C>T | non_coding_transcript_exon_variant | 3/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248432Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134730
GnomAD4 exome AF: 0.0000666 AC: 97AN: 1456238Hom.: 0 Cov.: 30 AF XY: 0.0000717 AC XY: 52AN XY: 724806
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152086Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2023 | The c.605C>T (p.T202I) alteration is located in exon 3 (coding exon 3) of the NAALADL2 gene. This alteration results from a C to T substitution at nucleotide position 605, causing the threonine (T) at amino acid position 202 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at